首页> 外国专利> DETERMINING A POTENTIAL FOR ATYPICAL CLINICAL EVENTS WHEN SELECTING CLINICAL AGENTS

DETERMINING A POTENTIAL FOR ATYPICAL CLINICAL EVENTS WHEN SELECTING CLINICAL AGENTS

机译:选择临床代理时确定非典型临床事件的可能性

摘要

Processes implemented within a computer system for preventing atypical clinical events resulting from administering unsuitable clinical agent(s) are provided. Initially, the processes involve receiving a list of possible clinical agent(s) that may be administered to a patient during a medical procedure. The processes further involve acquiring heredity data associated with the clinical agent(s) by comparing the clinical agent(s) against a data set or the patient's medical records. If the heredity data indicates that the patient scheduled to receive the clinical agent(s) would experience atypical clinical events as a potential outcome, a warning that the clinical agent(s) should not be administered by a clinician is presented or reference information about the atypical clinical event is output. Accordingly, a preemptive determination of the atypical clinical events potentially occurring upon administering the clinical agent(s) to the patient is made.
机译:提供了在计算机系统内实施的用于防止由于施用不合适的临床药剂而导致的非典型临床事件的过程。最初,该过程涉及接收在医疗程序期间可以施用于患者的可能的临床药剂的列表。所述过程还包括通过将临床药剂与数据集或患者的病历进行比较来获取与临床药剂相关的遗传数据。如果遗传数据表明计划接受临床药物的患者可能会经历非典型的临床事件作为潜在的后果,那么将发出警告,指示临床医生不应该使用临床药物,或者提供有关临床医生的参考信息。输出非典型的临床事件。因此,预先确定了在向患者施用临床药剂后可能发生的非典型临床事件。

著录项

  • 公开/公告号US2018122516A1

    专利类型

  • 公开/公告日2018-05-03

    原文格式PDF

  • 申请/专利权人 CERNER INNOVATION INC.;

    申请/专利号US201715855041

  • 发明设计人 MARK A. HOFFMAN;DAVID P. MCCALLIE JR.;

    申请日2017-12-27

  • 分类号G06Q50/22;

  • 国家 US

  • 入库时间 2022-08-21 13:02:06

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号